Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
By Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, R. Finn, Michael M Abecassis, Lewis R. Roberts, J. Heimbach. Hepatology, 2018
1,983 citations recorded by the source corpus.
Author(s): Marrero, Jorge A; Kulik, Laura M; Sirlin, Claude B; Zhu, Andrew X; Finn, Richard S; Abecassis, Michael M; Roberts, Lewis R; Heimbach, Julie K
Subfields: Epidemiology, Hepatology
View Paper: https://www.semanticscholar.org/paper/966a85c781b42162933d1e3b166646051c5688ce
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hepatology
Citations in the corpus
- Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases (2019, background): “(463) These risks justify surveillance strategies that include hepatic ultrasonography, with or without serum alphafetoprotein (AFP) level, every 6 months in patients with cirrhosis(466-468) and adherence to standard guidelines for detection of extrahepatic malignancy.”
- Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection (2019, methodology): “Ultrasound surveillance for HCC (with or without alpha-fetoprotein testing) every 6 months after treatment completion is recommended for patients with cirrhosis, regardless of achieving SVR.(78) Upper endoscopic surveillance for esophageal varices is recommended, consistent with AASLD guidance on po”